Alcohol-associated liver disease (ALD) is a major cause of chronic liver disease worldwide,
and comprises a spectrum of several different disorders, including simple steatosis …

Patients with inflammatory liver diseases, particularly alcohol-associated liver disease and
metabolic dysfunction-associated fatty liver disease (MAFLD), have higher incidence of …

Metabolic dysfunction-associated steatohepatitis (MASH) is the most prevalent cause of liver
disease worldwide, with a single approved therapeutic. Previous research has shown that …

The growing recognition of the role of the gut microbiome's impact on alcohol-related
diseases, especially in alcohol-associated liver disease, emphasizes the need to …

Summary Interleukin-22 (IL-22) is a vital cytokine that is dysregulated in various autoimmune
conditions including rheumatoid arthritis (RA), multiple sclerosis (MS), and Alzheimer's …

Introduction Alcoholic-associated liver diseases (ALD) are now widespread issues
worldwide. Alcoholic-induced chronic dysbiosis of the gut microbiota is one of the factors in …

Abstract Objective Interleukin (IL)-22 is a potential therapeutic protein for the treatment of
metabolic diseases such as obesity, type 2 diabetes, and metabolic dysfunction-associated …

“A healthy liver stands on a healthy gut” with the gut and its barriers representing the roots
that fuel the liver and expose it to an amazing diverse mixture of gut-derived material/agents …

Alcohol-associated hepatitis (AH) is an acute-on-chronic liver injury that occurs in patients
with chronic alcohol-associated liver disease (ALD). Patients with severe AH have high short …

Alcoholic liver disease (ALD) is a major cause of chronic liver disease. This term covers a
broad spectrum of liver lesions, from simple steatosis to alcoholic hepatitis and cirrhosis. The …